The diagnostic value of metagenomic next-generation sequencing in critically ill patients with sepsis: A retrospective cohort study
Chaozhong Li,Fang Wang,Wanrong Li,Guihu Sun,Dexing Yang,Ting Yang,Guohui Yang,Bo Liang,Yun Huang,Wenzhi Tang,Fei Li,Yujia Ye,Chuanyun Qian,Haiying Wu,Zhaohui Meng
DOI: https://doi.org/10.1097/md.0000000000039987
IF: 1.6
2024-10-15
Medicine
Abstract:Sepsis is a major healthcare problem that affects millions of people worldwide annually, and approximately 26.7% of sepsis patients die. [ 1–3 ] Early identification and proper management in the first few hours after sepsis can improve the prognosis; therefore, rapid and accurate identification of pathogenic bacteria is critical for successful outcomes. [ 4 ] A comprehensive routine microbiological test (CMT) is the traditional detection method of pathogenic microorganisms, which involves morphological detection, culture separation, biochemical detection, immunological tests, and nucleic acid detection. Because of its simplicity, rapidity, low technical requirements, and certain diagnostic sensitivity and specificity, CMT is still widely used in the clinic. Metagenomic next-generation sequencing (mNGS) is a new high-throughput sequencing method [ 5 ] that does not rely on traditional microbial culture to extensively analyze microbial groups (bacteria, fungi, viruses, and parasites) in clinical samples. By analyzing high-throughput sequencing and an intelligent algorithm, this technology can obtain the species information of suspected pathogenic microorganisms, thereby providing a nonbiased identification of bacteria, fungi, viruses, parasites, and other pathogenic microorganisms. [ 6 ] mNGS is suitable for patients with unexplained fever, difficult and critical illness, and immunodeficiency infection. [ 7–9 ] mNGS technology is also helpful to identify patients who may have bloodstream infections, particularly those with a fungal infection, mild symptoms, previous antibiotics, and early infection. [ 9 ] For patients with sepsis with abdominal infections, compared to the traditional methods of abdominal drainage smear, culture, and blood culture, plasma mNGS can provide early, noninvasive, and rapid microbiological diagnosis. [ 10 ] The mNGS technology should be considered an essential supplement to culture-based methods, particularly for unculturable or difficult-to-culture. [ 11 ] The mNGS is capable of identifying multiple pathogens in specimens from septic patients, and shows significantly higher positive rates than culture-based diagnostics. [ 12 ] The performance of mNGS in identifying pathogens for patients with sepsis is better than that of traditional detection methods, especially in immunocompromised patients. [ 13 ] This study aims to detect the difference between mNGS and CMT, and to explore the diagnostic efficacy of mNGS in critically ill patients with sepsis.
medicine, general & internal